Today, Convergent Therapeutics Inc., a clinical-stage biotechnology company, announced the details of a plenary presentation of a dose-escalation study evaluating the efficacy and safety of its...

EO-3021 demonstrated anti-tumor activity in preclinical models expressing varying levels of Claudin 18.2 EO-3021 induced a confirmed partial response in a patient with metastatic gastric cancer...

VAPORESSO, a world-leading vaping brand, has showcased its latest lineup of products at the Vapexpo France 2023, which runs from April 16 to April 17 at the Lyon Convention Centre. In a bid to...

-- Showcases New Partnership with Genomic Testing Cooperative to Oncology Testing Capabilities to Biopharma Researchers -- BALTIMORE, April 17, 2023 /PRNewswire/ -- Sysmex Inostics Inc., a...

AI recruitment software provider Sapia.ai is set to showcase innovative research across four sessions at the upcoming SIOP 2023 Conference in Boston. With the largest submission from an...

Innovative no-risk opportunity to lowering A1C in persons with diabetes reducing the cost of care TAMPA, Fla., April 17, 2023 /PRNewswire/ -- Smart Meter today announces a pay-for-performance...

– First preclinical data presented for the next generation of the UltraCAR-T platform utilizing a mesothelin (MSLN) chimeric antigen receptor (CAR) – – MSLN is overexpressed on multiple...

ZB131 is a first-in-class humanized monoclonal antibody targeting cancer-specific plectin (CSP), which is expressed on the surface of cancer cells in many solid tumors New, preclinical research...

Bugworks Research Inc., a clinical-stage biopharmaceutical company, is set to present its latest research findings on the novel bacterial topoisomerase inhibitor, BWC0977 at the upcoming 33rd...

Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced...